The world’s best drug for treating malaria, a medicine that is the key to saving millions of lives in Africa and beyond, is losing its efficacy in a much larger swath of territory than was previously known, according to research that was released Friday.The study, in The Lancet Infectious Diseases, a medical journal, raises the troubling prospect that resistance to the drug, artemisinin, might one day severely hamper treatment of a disease that kills hundreds of thousands of people every year.
Read more, via NYTimes.com.
Leave a Reply
You must be logged in to post a comment.